NASDAQ
ADMP

Adamis Pharma

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Adamis Pharma Stock Price

Vitals

Today's Low:
$0.1272
Today's High:
$0.1419
Open Price:
$0.1389
52W Low:
$0.12
52W High:
$1.08
Prev. Close:
$0.1389
Volume:
643667

Company Statistics

Market Cap.:
$0.020 billion
Book Value:
0.047
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-4306%
Gross Profit TTM:
$-0.005 billion
Gross Profit TTM:
$-0.005 billion
Profit Margin:
0%
Return on Assets TTM:
-52.6%
Return on Equity TTM:
-117.3%

Company Profile

Adamis Pharma had its IPO on 1995-08-14 under the ticker symbol ADMP.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Adamis Pharma has a staff strength of 0 employees.

Stock update

Shares of Adamis Pharma opened at $0.14 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.13 - $0.14, and closed at $0.13.

This is a -3.53% slip from the previous day's closing price.

A total volume of 643,667 shares were traded at the close of the day’s session.

In the last one week, shares of Adamis Pharma have increased by 0%.

Adamis Pharma's Key Ratios

Adamis Pharma has a market cap of $0.020 billion, indicating a price to book ratio of 2.994 and a price to sales ratio of 25.28.

In the last 12-months Adamis Pharma’s revenue was $0.001 billion with a gross profit of $-0.005 billion and an EBITDA of $-0.033 billion. The EBITDA ratio measures Adamis Pharma's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Adamis Pharma’s operating margin was -4306% while its return on assets stood at -52.6% with a return of equity of -117.3%.

In Q2, Adamis Pharma’s quarterly earnings growth was a positive 0% while revenue growth was a negative 96.9%.

Adamis Pharma’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.273 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adamis Pharma’s profitability.

Adamis Pharma stock is trading at a EV to sales ratio of 16.02 and a EV to EBITDA ratio of -0.424. Its price to sales ratio in the trailing 12-months stood at 25.28.

Adamis Pharma stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Adamis Pharma ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Adamis Pharma ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Adamis Pharma’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Adamis Pharma's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Adamis Pharma paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.13
52-Week High
$1.08
52-Week Low
$0.12
Analyst Target Price
$0.42

Adamis Pharma stock is currently trading at $0.13 per share. It touched a 52-week high of $1.08 and a 52-week low of $1.08. Analysts tracking the stock have a 12-month average target price of $0.42.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Adamis Pharma

The stock symbol (also called stock or share ticker) of Adamis Pharma is ADMP

The IPO of Adamis Pharma took place on 1995-08-14

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$10.6
-0.25
-2.3%
Alkermes Plc (ALKS)
$24.06
0.81
+3.48%
$21.69
3.41
+18.65%
$12.97
-0.23
-1.71%
$2.11
-0.22
-9.44%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California.

Address

11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US